FDA approves penpulimab-kcqx

On April 23, 2025, the Food and Drug Administration approved penpulimab-kcqx (Akeso Biopharma Co., Ltd.) with cisplatin or carboplatin and gemcitabine for the first-line treatment of adults with recurrent or metastatic non-keratinizing nasopharyngeal carcinoma (NPC)....

reBom Co., Ltd. – 682811

Delivery Method: VIA EMAIL WITH READ RECEIPT Reference #: 320-24-49 Product: Drugs Recipient: Recipient Name Mr. Kwangjeon Lee reBom Co., Ltd. 6 Myeonghaksandanseo-roYeondong-myeonSejong30068South Korea jake@rebom.kr Issuing Office: Center for Drug Evaluation and...

Optikem International Inc. – 680264

Delivery Method: VIA EMAIL CONFIRMED DELIVERY Product: Drugs Recipient: Recipient Name Ms. Sally A. Cook Recipient Title President Optikem International Inc. 2172 South Jason StreetDenver, CO 80223United States optikemint@aol.com Issuing Office: Division of...